Chronic myeloid leukemia (CML) starts in the blood-forming cells in the bone marrow and spreads to the blood. The symptoms and treatment options can vary according to the stage of CML. Share on ...
The BCR/ABL fusion gene originating from a t(9;22)(q34;q11.2) chromosomal translocation is the molecular marker of chronic myeloid leukemia (CML). In the vast majority of CML cases the breakpoint on ...
Jian-Hua Mao, Xiao-Yan Sun, Jian-Xiang Liu, Qun-Ye Zhang, Ping Liu, Qiu-Hua Huang, Keqin Kathy Li, Quan Chen, Zhu Chen, Sai-Juan Chen Proceedings of the National Academy of Sciences of the United ...
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...
June 20, 2011 (London, United Kingdom) — With 24 months of follow-up, nilotinib continues to show superiority over imatinib for the treatment of newly diagnosed patients with chronic myeloid leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback